Literature DB >> 23788179

Magnetic nanoparticles as contrast agents in the diagnosis and treatment of cancer.

Juan Gallo1, Nicholas J Long, Eric O Aboagye.   

Abstract

Magnetic nanoparticles represent one of the most advanced developments in the application of nanotechnology to human health. To date, their clinical application has been restricted to the diagnosis of hepatic lesions and lymph node metastasis but functionalization of these materials with biomolecules as targeting motifs, and the inclusion of therapeutic drugs in their composition, is certain to make a substantial impact within biomedicine. One of the diseases that could benefit from these advances is cancer, as early diagnosis and effective treatment are crucial for a patient's survival and quality of life. This review will examine the recent uses of magnetic particles in cancer diagnosis and treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23788179     DOI: 10.1039/c3cs60149h

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  26 in total

Review 1.  Nanotechnologies for biomedical science and translational medicine.

Authors:  James R Heath
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-24       Impact factor: 11.205

2.  Design and characterization of lisinopril-loaded superparamagnetic nanoparticles as a new contrast agent for in vitro, in vivo MRI imaging, diagnose the tumors and drug delivery system.

Authors:  Sajjad Abbasi Pour; Hamid Reza Shaterian
Journal:  J Mater Sci Mater Med       Date:  2017-05-11       Impact factor: 3.896

Review 3.  Enhancing magnetic resonance imaging with contrast agents for ultra-high field strengths.

Authors:  Akhila N W Kuda-Wedagedara; Matthew J Allen
Journal:  Analyst       Date:  2014-09-21       Impact factor: 4.616

4.  Iodinated oil-loaded, fluorescent mesoporous silica-coated iron oxide nanoparticles for magnetic resonance imaging/computed tomography/fluorescence trimodal imaging.

Authors:  Sihan Xue; Yao Wang; Mengxing Wang; Lu Zhang; Xiaoxia Du; Hongchen Gu; Chunfu Zhang
Journal:  Int J Nanomedicine       Date:  2014-05-21

5.  CXCR4-targeted and MMP-responsive iron oxide nanoparticles for enhanced magnetic resonance imaging.

Authors:  Juan Gallo; Nazila Kamaly; Ioannis Lavdas; Elizabeth Stevens; Quang-De Nguyen; Marzena Wylezinska-Arridge; Eric O Aboagye; Nicholas J Long
Journal:  Angew Chem Int Ed Engl       Date:  2014-07-15       Impact factor: 15.336

6.  Magnetic Beads Enhance Adhesion of NIH 3T3 Fibroblasts: A Proof-of-Principle In Vitro Study for Implant-Mediated Long-Term Drug Delivery to the Inner Ear.

Authors:  Pooyan Aliuos; Jennifer Schulze; Markus Schomaker; Günter Reuter; Stefan R O Stolle; Darja Werner; Tammo Ripken; Thomas Lenarz; Athanasia Warnecke
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

Review 7.  Mesenchymal Stem Cells Engineered by Nonviral Vectors: A Powerful Tool in Cancer Gene Therapy.

Authors:  Yuan Ding; Chenyang Wang; Zhongquan Sun; Yingsheng Wu; Wanlu You; Zhengwei Mao; Weilin Wang
Journal:  Pharmaceutics       Date:  2021-06-21       Impact factor: 6.321

8.  Tumor-targeted responsive nanoparticle-based systems for magnetic resonance imaging and therapy.

Authors:  Ronak Savla; Olga B Garbuzenko; Suzie Chen; Lorna Rodriguez-Rodriguez; Tamara Minko
Journal:  Pharm Res       Date:  2014-06-13       Impact factor: 4.200

9.  Folic acid-targeted iron oxide nanoparticles as contrast agents for magnetic resonance imaging of human ovarian cancer.

Authors:  He Zhang; Jingchao Li; Yong Hu; Mingwu Shen; Xiangyang Shi; Guofu Zhang
Journal:  J Ovarian Res       Date:  2016-03-29       Impact factor: 4.234

10.  Dual-Color Fluorescence Imaging of Magnetic Nanoparticles in Live Cancer Cells Using Conjugated Polymer Probes.

Authors:  Minjie Sun; Bin Sun; Yun Liu; Qun-Dong Shen; Shaojun Jiang
Journal:  Sci Rep       Date:  2016-03-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.